company background image
IDXX logo

IDEXX Laboratories WBAG:IDXX Stock Report

Last Price

€430.30

Market Cap

€35.7b

7D

-1.7%

1Y

4.2%

Updated

10 Oct, 2024

Data

Company Financials +

IDEXX Laboratories, Inc.

WBAG:IDXX Stock Report

Market Cap: €35.7b

IDXX Stock Overview

Develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally.

IDXX fundamental analysis
Snowflake Score
Valuation0/6
Future Growth4/6
Past Performance3/6
Financial Health6/6
Dividends0/6

Rewards

Risk Analysis

IDXX passed our risk checks.

IDEXX Laboratories, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for IDEXX Laboratories
Historical stock prices
Current Share PriceUS$430.30
52 Week HighUS$535.60
52 Week LowUS$359.10
Beta1.33
11 Month Change-4.38%
3 Month Change-6.09%
1 Year Change4.19%
33 Year Change-22.02%
5 Year Change69.61%
Change since IPO196.45%

Recent News & Updates

Recent updates

Shareholder Returns

IDXXAT Medical EquipmentAT Market
7D-1.7%-0.4%0.5%
1Y4.2%20.5%5.6%

Return vs Industry: IDXX underperformed the Austrian Medical Equipment industry which returned 21% over the past year.

Return vs Market: IDXX underperformed the Austrian Market which returned 5.6% over the past year.

Price Volatility

Is IDXX's price volatile compared to industry and market?
IDXX volatility
IDXX Average Weekly Movement4.1%
Medical Equipment Industry Average Movement5.6%
Market Average Movement3.6%
10% most volatile stocks in AT Market6.1%
10% least volatile stocks in AT Market2.0%

Stable Share Price: IDXX has not had significant price volatility in the past 3 months compared to the Austrian market.

Volatility Over Time: IDXX's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
198311,000Jay Mazelskywww.idexx.com

IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory diagnostic instruments, and services for biomedical research community.

IDEXX Laboratories, Inc. Fundamentals Summary

How do IDEXX Laboratories's earnings and revenue compare to its market cap?
IDXX fundamental statistics
Market cap€35.73b
Earnings (TTM)€773.50m
Revenue (TTM)€3.46b

46.1x

P/E Ratio

10.3x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
IDXX income statement (TTM)
RevenueUS$3.78b
Cost of RevenueUS$1.50b
Gross ProfitUS$2.29b
Other ExpensesUS$1.44b
EarningsUS$845.63m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

Oct 31, 2024

Earnings per share (EPS)10.27
Gross Margin60.41%
Net Profit Margin22.34%
Debt/Equity Ratio59.8%

How did IDXX perform over the long term?

See historical performance and comparison